Previous studies have suggested pre-existing CKD, raised beta-2 microglobulin (reflecting a high tumour burden), and the presence of mucositis grade 3 or 4 as independent prognostic factors for developing CKD after ASCT have been associated with increased morbidity [6]. This evidence concerns the gene B2M and chronic kidney disease.